135 related articles for article (PubMed ID: 2604936)
21. The treatment of neuroblastoma with 131I-MIBG.
Mastrangelo R
Med Pediatr Oncol; 1987; 15(4):157-8. PubMed ID: 3657703
[No Abstract] [Full Text] [Related]
22. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: the experience of an Italian Study Group.
Bestagno M; Guerra P; Puricelli GP; Colombo L; Calculli G
Med Pediatr Oncol; 1987; 15(4):203-4. PubMed ID: 3657708
[TBL] [Abstract][Full Text] [Related]
23. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
[No Abstract] [Full Text] [Related]
24. Neuroblastoma today.
Ferster A; Schots R; Maurus R; Otten J
Biomed Pharmacother; 1988; 42(4):247-55. PubMed ID: 3056532
[TBL] [Abstract][Full Text] [Related]
25. 131I-metaiodobenzylguanidine treatment in neuroblastoma: report of two cases.
Cottino F; Mussa GC; Madon E; Favero A; Silvestro L; Grazia G
Med Pediatr Oncol; 1987; 15(4):216-9. PubMed ID: 3657711
[TBL] [Abstract][Full Text] [Related]
26. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV.
Voûte PA; van der Kleij AJ; De Kraker J; Hoefnagel CA; Tiel-van Buul MM; Van Gennip H
Eur J Cancer; 1995; 31A(4):596-600. PubMed ID: 7576976
[TBL] [Abstract][Full Text] [Related]
28. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
29. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
[TBL] [Abstract][Full Text] [Related]
31. Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma.
Mairs RJ; Angerson WJ; Babich JW; Murray T
Prog Clin Biol Res; 1991; 366():495-501. PubMed ID: 2068165
[TBL] [Abstract][Full Text] [Related]
32. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
[TBL] [Abstract][Full Text] [Related]
33. Radiolabelled mIBG in the treatment of neuroblastoma.
Gaze MN; Wheldon TE
Eur J Cancer; 1996 Jan; 32A(1):93-6. PubMed ID: 8695251
[No Abstract] [Full Text] [Related]
34. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
[No Abstract] [Full Text] [Related]
35. Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
Sisson JC; Hutchinson RJ; Carey JE; Shapiro B; Johnson JW; Mallette SA; Wieland DM
Eur J Nucl Med; 1988; 14(7-8):337-40. PubMed ID: 3181182
[TBL] [Abstract][Full Text] [Related]
36. [Pediatric oncology. Nursing aspects of I-131-MIBG].
Damen VJ
TVZ; 1989 Apr; 43(8):248-50. PubMed ID: 2500738
[No Abstract] [Full Text] [Related]
37. Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic use.
Wafelman AR; Hoefnagel CA; Beijnen JH
Nucl Med Commun; 1993 Sep; 14(9):819-22. PubMed ID: 8233249
[TBL] [Abstract][Full Text] [Related]
38. Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Klingebiel T; Bruchelt G; Kaleva N; Wollmann H; Handgretinger R; Treuner J; Gupta D; Niethammer D
Prog Clin Biol Res; 1991; 366():509-12. PubMed ID: 2068167
[No Abstract] [Full Text] [Related]
39. Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.
Klingebiel T; Berthold F; Treuner J; Schwabe D; Fischer M; Feine U; Maul FD; Waters W; Wehinger H; Niethammer D
Med Pediatr Oncol; 1991; 19(2):84-8. PubMed ID: 2011100
[TBL] [Abstract][Full Text] [Related]
40. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
Klingebiel T; Reuland P; Feine U; Niethammer D
Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
